CClinicalTrials.gg
CompletedNCT07465211RCTUpdated Mar 11, 2026

Comparative Evaluation of Clinical Success of BIOFLX Crowns and SSC in Primary Molars

An interventional study of US Public Health Service modified criteria and The parental satisfaction in Dental Caries and Restored Decayed Teeth and Post-operative Sensitivity, sponsored by satish vishwanathaiah. Completed at 1 site in India. Open to participants aged Up to 10 Years. Per ClinicalTrials.gov, last updated 2026-03-11.

Sponsored by satish vishwanathaiah · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Jun 2025, registered Jan 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
Up to 10 Years
Sex
All
01

Study summary

Although Stainless steel crowns (SSC) are the gold standard treatment modality for multi-surface carious lesion in paediatric patients, the quest for metal free, aesthetic restoration with comparable features that of SSC still continues. This research compares the clinical effectiveness of Bioflx crowns (Kids-e-dental)TM to the "gold standard" Stainless Steel crowns (Rainbow crowns)TM

Read the detailed description

A split mouth trial was conducted among 36 children of age 6-8 years, in which Bioflx crowns (Kids-e-dental)TM and Stainless Steel crowns (Rainbow crowns)TM are placed in each primary molar in bilateral or contra-lateral sides. The clinical effectiveness is evaluated using US Public Health Service modified criteria at baseline and after 1,3,6 and 12 months. The parental satisfaction of restoration is recorded using a 5-point Likert scale at baseline and 12 months. Descriptive statistics and intra-group comparison were analyzed using Chi-square test, while intergroup comparison was analyzed using Mann-Whitney test.

02

Conditions studied

  • Dental Caries
  • Restored Decayed Teeth and Post-operative Sensitivity

Browse trials for

03

In context

Dental Caries

1,109 studies on the registry are indexed under Dental Caries; 197 are open to participants now.

This study's enrollment of 36 is below the median of 60 across 916 interventional studies indexed under Dental Caries.

Browse Dental Caries studies →

Lead sponsor

This is the only study on the registry with satish vishwanathaiah as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

    • At least two primary molars (contra-lateral or opposing side) needing full coverage restoration.

      • Consent of patient/legal guardian of the child
      • Cooperative behaviour based on Frankel behaviour rating 3 or 4 (positive or definitely positive)

Exclusion criteria

Exclusion Criteria:

    • Parent not willing to give consent.

      • Child with special health care needs
      • Uncooperative child based on Frankel rating1or 2 (definitely negative or negative)
      • History of Ni-Cr allergy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    BIOFLX crowns ( kids-e-dental)

    Crowns placed

    Procedure: US Public Health Service modified criteria · Procedure: The parental satisfaction

  • Active comparator
    Stainless steel crowns (Rainbow crowns)

    Crowns

    Procedure: US Public Health Service modified criteria · Procedure: The parental satisfaction

Interventions

  • ProcedureUS Public Health Service modified criteria

    1, 3 , 6 and 12 months

  • ProcedureThe parental satisfaction

    rated as (1) strongly disagree, (2) disagree, (3) not sure, (4) agree, and (5) strongly agree for five variables - color, size, shape, fit and overall satisfaction. The score 1 and 2 were combined as satisfied, Score 3 indicated neutral response, Score 4 and 5 were combined as dissatisfied

06

What researchers measure

Primary outcomes

  1. US Public Health Service (USPHS) modified criteria

    The following variableswere assessed; retention, color match, marginal discoloration and adaptation, secondary caries, wear and post-operative sensitivity

    Time frame: 1st month, 3rd month, 6th month and 12 th month

Secondary outcomes

  1. The parental satisfaction

    5-point Likert scale developed by Alkhouli et al rated as (1) strongly disagree, (2) disagree, (3) not sure, (4) agree, and (5) strongly agree for five variables - color, size, shape, fit and overall satisfaction. The score 1 and 2 were combined as satisfied, Score 3 indicated neutral response, Score 4 and 5 were combined as dissatisfied

    Time frame: 1st month and 12th month

07

Study locations

1 site
  • Mahatma Gandhi dental college and hospital
    Jaipur, Rajasthan 302022, India
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07465211
Lead sponsor
satish vishwanathaiah
Responsible party
satish vishwanathaiah (Associate professor, University of Jazan) — Sponsor-investigator
First posted
Mar 11, 2026
Start date
Jun 22, 2025
Primary completion
Sep 25, 2025
Completion
Sep 27, 2025
Last update
Mar 11, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion